News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24 Results
Type
Article (6)
Company Profile (1)
Press Release (17)
Section
Business (10)
Drug Development (3)
FDA (1)
Job Trends (4)
News (11)
Tag
Alliances (3)
Approvals (1)
Best Places to Work (4)
Biotechnology (1)
COVID-19 (2)
CRISPR (2)
Cystic fibrosis (1)
Diagnostics (1)
Earnings (1)
Events (6)
FDA (1)
Gene editing (2)
Infectious disease (2)
Job creations (1)
People (5)
Preclinical (1)
Rare diseases (1)
Startups (2)
Date
Last 365 days (5)
2025 (4)
2024 (3)
2023 (2)
2022 (7)
2021 (3)
2020 (3)
2018 (2)
Location
California (5)
Europe (1)
Northern California (1)
United States (5)
24 Results for "mammothbiosci".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mammoth Biosciences
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics.
Business
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Mammoth Biosciences, Inc., today announced a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types.
April 25, 2024
·
10 min read
Press Releases
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
May 5, 2025
·
4 min read
Press Releases
Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
May 1, 2025
·
2 min read
Press Releases
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
January 31, 2025
·
4 min read
Business
Jennifer Doudna’s Mammoth Links with Vertex in $700 Million Ultra-Small CRISPR Deal
Mammoth Biosciences just announced a collaboration with Vertex to develop in vivo gene-editing therapeutics for patients with either of two serious, but not-yet-disclosed diseases.
October 26, 2021
·
4 min read
·
Gail Dutton
Press Releases
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Biotech Bay
Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products For Therapeutics and Diagnostics
Already the leader in CRISPR-based disease detection, the latest round will drive Mammoth’s robust platform for protein discovery to extend into gene-editing and therapeutics applications.
February 5, 2020
·
4 min read
Biotech Bay
Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy
Mammoth Biosciences today announced that Lucas Harrington, Ph.D., Mammoth’s co-founder and Chief Scientific Officer, will present new preclinical data at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore, May 7 - 11, 2024.
May 2, 2024
·
3 min read
Biotech Bay
Mammoth Biosciences to Present at the 2023 Annual Meeting of the American Society of Gene and Cell Therapy
Mammoth Biosciences today announced Janice Chen, Ph.D., chief technology officer and co-founder of Mammoth, will present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles, CA, May 16 - 20, 2023.
May 8, 2023
·
2 min read
1 of 3
Next
